Archives
-
Cyclosporin A: Mechanism, Evidence, and Limits
2026-10-03
Cyclosporin A is a widely studied immunosuppressive cyclic peptide whose best-established research mechanism involves a cyclophilin A–calcineurin pathway that limits NF-AT-dependent T-cell activation. This overview separates findings from interpretation, compares pharmacological and genetic evidence, and defines the boundaries of applications in transplantation, mitochondrial biology, and autoimmune disease research.
-
Affordable GRO-seq for Bread Wheat Nascent RNA
2026-10-02
This protocol adapts Global Run-On sequencing (GRO-seq) for allohexaploid bread wheat by adding rRNA depletion after nuclear RNA isolation and before nascent RNA immunoprecipitation. The authors report a 20-fold increase in the proportion of valid data, offering a more economical route to enhancer-transcription profiling in large, complex genomes.
-
YC-1: Mechanism, Assay Design, and Cancer Research
2026-10-01
YC-1 is a dual-function sGC activator and HIF-1α pathway probe for cancer research. This guide connects its hypoxia biology to rigorous orthogonal assay design, using a recent Amplex Red protocol to clarify controls, interpretation, and experimental limitations.
-
Red Blood Cell Membrane Bending Rigidity
2026-10-01
This study separates the bending mechanics of the red blood cell cytoplasmic membrane from those of the underlying spectrin network. By combining X-ray diffuse scattering, neutron spin-echo spectroscopy, and molecular dynamics simulations, it shows that the isolated membrane is considerably softer than many previously reported whole-cell or composite-membrane measurements suggest.
-
c-Myc tag Peptide for Assay Deconvolution
2026-09-30
The c-Myc Peptide enables controlled displacement of tagged fusion proteins from anti-c-Myc antibodies. This article explains how to use that competition strategy to separate assay binding effects from transcription factor biology, with practical insights from selective autophagy research.
-
1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine
2026-09-30
PP 3 provides a structurally matched negative control for PP 2, helping separate Src-dependent biology from compound, vehicle, and pathway-level artifacts. Its value is especially clear in vascular assays where Src inhibition, NADPH oxidase-derived ROS, and L-type calcium-channel activity may produce overlapping phenotypes.
-
c-Myc Peptide: Immunoassay Workflow Guide
2026-09-29
Use the c-Myc Peptide as a controlled competition reagent to test antibody specificity, release tagged fusion proteins, and troubleshoot immunoassay background. This workflow connects practical epitope-displacement experiments with mechanistic studies of transcription factor regulation while clearly separating what the peptide can validate from what it cannot prove.
-
Trifluoperazine 2HCl: Assay Workflows
2026-09-29
Build reproducible dopamine D2 receptor, macrophage ROS/autophagy, and cancer-model assays with a fresh, concentration-controlled Trifluoperazine 2HCl workflow. The guide separates receptor engagement from downstream phenotypes and uses the PDK4 inhibitor literature to improve assay staging without implying a shared molecular target.
-
X-press Tag Peptide for RHEB Purification
2026-09-28
X-press Tag Peptide combines affinity capture, Anti-Xpress antibody detection, and enterokinase-compatible release in one N-terminal design. This article translates the UBE2F–SAG–RHEB–mTORC1 findings into practical purification, validation, and troubleshooting workflows for recombinant protein studies.
-
3X (DYKDDDDK) Peptide: Evidence and Use
2026-09-28
The 3X (DYKDDDDK) Peptide is a synthetic FLAG epitope reagent for detecting and isolating recombinant proteins with accessible tags. This evidence-focused guide summarizes its stated antibody recognition, solubility, storage, and metal-related caveats while distinguishing product information from gastric-cancer research findings.
-
Legionella VipF Acetylates eIF3 to Suppress Translation
2026-09-27
Syriste and colleagues show that the conserved Legionella effector family represented by VipF targets eukaryotic eIF3, acetylating lysines in the eIF3-K subunit and suppressing translation in vitro. Structural, biochemical, interaction, and translation assays connect the effector’s tandem GNAT domains to a potential host-manipulation strategy, while leaving its effects during infection to be established.
-
YC-1: Practical Hypoxia and Cancer Assay Guide
2026-09-26
YC-1 offers a research tool for examining hypoxia-inducible factor 1 signaling and soluble guanylyl cyclase activity, with dossier-described effects on HIF-1α expression and transcriptional activity. It is intended for controlled laboratory research—not clinical use—and its water insolubility makes it unsuitable for workflows that require an aqueous stock without a compatible vehicle strategy.
-
Trifluoperazine 2HCl: Assay Design Beyond D2
2026-09-25
Trifluoperazine 2HCl is a potent dopamine D2 receptor inhibitor, but its value in research depends on separating receptor-level effects from broader cellular phenotypes. This guide connects practical assay design with a distinct lesson from PDK4 inhibitor research: build evidence in layers, and do not mistake a promising phenotype for proof of mechanism.
-
FLAG tag Peptide: Probing Exosome Sorting Pathways
2026-09-25
The FLAG tag Peptide (DYKDDDDK) can support controlled purification and detection of tagged proteins used to investigate exosome biology. This article connects FLAG-based assay design to the RAB31 pathway, while distinguishing what a tag can measure from what it cannot prove.
-
JHU-083 for Reproducible Glutaminase Assays
2026-09-24
A scenario-driven guide to using JHU-083 (SKU BA7770) in glutaminase pathway research, with practical guidance on assay design, handling, and interpretation. It distinguishes supported cerebral CD11b and experimental cerebral malaria applications from exploratory redox questions.